Tegoprazan Shows Superior Efficacy and Safety in Treating Esophageal Conditions in Phase 3 trial Dr. Kamal Kant Kohli9 May 2025 8:45 PM ISTIn a phase 3 trial Tegoprazan Shows Superior Efficacy and Safety in Treating Esophageal Conditions. It was found that Tegoprazan acted faster and was...
Potassium-Competitive Acid Blockers: AGA Review Offers Insights on Optimal Use in GI Disorders Medha Baranwal27 Jan 2025 8:30 PM ISTUSA: The American Gastroenterological Association (AGA) has released a Clinical Practice Update (CPU) aimed at integrating potassium-competitive acid...
Dr Reddys Laboratories gets CDSCO Panel Nod to import, market Tegoprazan for gastrointestinal diseases Susmita Roy28 Nov 2024 6:00 PM ISTNew Delhi: In a significant development, the pharmaceutical major Dr Reddys Laboratories has got the go-ahead from the Subject Expert Committee (SEC)...
Dr. Reddy's Gets CDSCO Panel Nod To Study Tegoprazan for gastrointestinal diseases Dr. Divya Colin4 July 2023 6:00 PM ISTNew Delhi: The drug major Dr. Reddy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Revise Phase III CT protocol: CDSCO Panel Tells Dr Reddy's over Tegoprazan Dr. Divya Colin15 April 2023 6:00 PM ISTNew Delhi: In response to the proposal to conduct a Phase III clinical trial presented by the drug major Reddy's Laboratories, the Subject Expert...
Dr Reddys Labs, HK inno.N Corporation ink pact to commercialize Tegoprazan in India, 6 key emerging Markets Ruchika Sharma12 May 2022 12:19 PM ISTThe agreement grants Dr. Reddy's the exclusive rights to develop and commercialise Tegoprazan under its own trademark in these markets for 10 years...
